Abstract
We thank Dr. Tirelli, Dr. Carbone, Dr. Francia and Dr. Di Francia for the interest they have taken in our paper “Efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial”, and appreciate their comments (1,2).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
